ERLIN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.590200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.840200E-01
Normal-vs-Stage2
9.778200E-01
Normal-vs-Stage3
3.546600E-01
Normal-vs-Stage4
3.177200E-01
Stage1-vs-Stage2
6.298400E-01
Stage1-vs-Stage3
1.241180E-01
Stage1-vs-Stage4
4.681400E-01
Stage2-vs-Stage3
8.00520000000526E-05
Stage2-vs-Stage4
1.650980E-01
Stage3-vs-Stage4
4.203800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.263800E-01
Normal-vs-AfricanAmerican
6.811800E-01
Normal-vs-Asian
8.273400E-01
Caucasian-vs-AfricanAmerican
4.170400E-01
Caucasian-vs-Asian
7.629800E-01
AfricanAmerican-vs-Asian
4.091800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.692800E-01
Normal-vs-Female
9.555800E-01
Male-vs-Female
9.440800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.067400E-01
Normal-vs-Age(41-60Yrs)
8.698000E-01
Normal-vs-Age(61-80Yrs)
9.112800E-01
Normal-vs-Age(81-100Yrs)
9.474400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.252560E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.427400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.425600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.358800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.365200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.864600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.926200E-01
Normal-vs-Daily Drinker
7.370800E-01
Normal-vs-Weekly Drinker
8.725800E-01
Normal-vs-Occasional Drinker
6.375600E-01
Normal-vs-Social Drinker
9.078800E-01
Non Drinker-vs-Daily Drinker
9.878600E-01
Non Drinker-vs-Weekly Drinker
5.606000E-01
Non Drinker-vs-Occasional Drinker
3.938000E-02
Non Drinker-vs-Social Drinker
2.242800E-01
Daily Drinker-vs-Weekly Drinker
6.832600E-01
Daily Drinker-vs-Occasional Drinker
1.327420E-01
Daily Drinker-vs-Social Drinker
3.974200E-01
Weekly Drinker-vs-Occasional Drinker
2.625000E-01
Weekly Drinker-vs-Social Drinker
6.364800E-01
Occasional Drinker-vs-Social Drinker
4.819400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.788440E-01
Normal-vs-Grade 2
4.294200E-02
Normal-vs-Grade 3
7.083800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.265900E-02
Grade 1-vs-Grade 3
1.070080E-02
Grade 1-vs-Grade 4
1.788440E-01
Grade 2-vs-Grade 3
8.668200E-02
Grade 2-vs-Grade 4
4.294200E-02
Grade 3-vs-Grade 4
7.083800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.698600E-01
Normal-vs-NonDiabetic
9.433600E-01
Diabetic-vs-NonDiabetic
2.648600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.371000E-01
Normal-vs-NoPancreatitis
9.339600E-01
Pancreatitis-vs-NoPancreatitis
3.293600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.557200E-01
Normal-vs-N1
9.744400E-01
N0-vs-N1
4.649000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.408800E-01
Normal-vs-TP53-NonMutant
9.510800E-01
TP53-Mutant-vs-TP53-NonMutant
4.231800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
